---
layout: post
title: METRC POvIV
category: trauma
---

## Study Contact:  
Eric McVey
434-243-5382

### IRB-HSR 17432
Clinic Visit Registration:
17432-Weiss

##  Inclusion Criteria
- Patients with any fractures of any bone at or proximal to and including the tarsal/metatarsal joint (Lisfranc) or proximal to the carpal joints (includes distal radius fractures), excluding the spine, treated with any type of internal fixation, or
- Patients undergoing fusion of any bone at or proximal to and including the subtalar joint or radial carpal joint, (excluding the spine) that develop a post op wound infection at any time.
- Patients diagnosed with a wound infection of the study injury, defined as deep culture positive after operative debridement
- Patients who are English or Spanish competent.
- Patients aged 18 – 84.
- Patients with bacteria susceptible to both PO and IV antibiotics.
- Patients able to be treated for their infection at the METRC facility for at least 12 months following definitive surgical procedure
- Patients may have multiple eligible study-eligible injuries.
- Patients may have temporary external fixation prior to definitive fixation.
- Patients may have received antibiotics prior to operative wound debridement.
- Patient is able to obtain study medication(s).
- Patient may be pregnant at the time of screening.

##  Exclusion Criteria

- Patients who have high risk of amputation of the study limb (based on opinion of the initial managing physician).
- Patients undergoing treatment with any other investigational therapy within the month preceding implantation or planned within the 12 months following implantation.
- Patients with history of chronic infection at the site of study injury, defined as: patients with chronic osteomyelitis identified by radiographic erosion or sequestrum; or patients with more than one instance of surgical treatment of infection and approximately 6 week course of antibiotics.
- Patients with pathological fractures; a known history of Paget’s disease.
- Patients for whom the definitive treatment of the study injury was an external fixator.
- Patients who are currently on Selective Serotonin Reuptake Inhibitor (SSRI) medication (e.g. Zoloft, Prozac, Celexa), and bacteria is MRSA
- Patients with cultures positive in thio only.
- Patients who are incarcerated or who have unstable housing situations due to concerns regarding ability to receive home care, adherence phone calls, and maintain follow up. .
- Patients or designated proxy who are unwilling to provide consent.
- Patients with a history of IV drug use who in the investigator’s opinion are unsuitable candidates for IV therapy.
- Patients likely to have severe problems maintaining follow-up, including patients diagnosed with a severe psychiatric conditions, patients who live too far outside the hospital’s catchment area.
- Patients with traumatic brain injury or who are intellectually challenged and who lack adequate family support to ensure adherence to the protocol.
- Patients unable to swallow oral medications or without adequately functioning GI tract.
- Patients who, based upon the clinical judgment of the treating clinician, are NOT equally suited for treatment with either oral or intravenous antibiotics (i.e., those for whom there is a clinical treatment preference).

## Study Summary

- Baseline.  Performed as close to discharge from hospital as feasible
- Week 1- lab tests prn, Vanderbilt call center phone call to pt.
- Week 2 – clinic visit, lab tests prn, Vanderbilt call center phone call to pt., clinic follow up form
- Week 3-5 - lab tests prn, Vanderbilt call center phone call to pt.
- Week 6 - clinic visit, lab tests prn, Vanderbilt call center phone call to pt, clinic follow up form.
- Weeks 12, 26 –clinic visit, ongoing Med hx, clinic follow up form
- Week 52 -  clinic visit, ongoing Med hx, clinic follow up form, Surveys


## Payment

Complete vendor registration through UVA Procurement at: https://www.procurement.virginia.edu/pagevendorregistrationform

Contact Sarah Spangler (cc Eric McVey) with patient name, MRN, DOS, study visit
